Fresenius SE and Company... (QX) (USOTC:FSNUY)
Historical Stock Chart
2 Months : From Dec 2019 to Feb 2020
By Kim Richters
Fresenius SE & Co. (FRE.XE) said Tuesday that its subsidiary Fresenius Kabi has formed a joint venture with pharma peers Bio-Techne Corp. (TECH) and Wilson Wolf.
The collaboration will focus on providing technology to develop and commercialize cell and gene therapies, German health-care company Fresenius said of its medicines division's venture.
The company didn't disclose any financial details of the joint venture, which is equally owned by the three parties.
Write to Kim Richters at email@example.com
(END) Dow Jones Newswires
January 21, 2020 09:09 ET (14:09 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.